123 related articles for article (PubMed ID: 11738720)
1. Existence of beta-methylnorleucine in recombinant hirudin produced by Escherichia coli.
Muramatsu R; Negishi T; Mimoto T; Miura A; Misawa S; Hayashi H
J Biotechnol; 2002 Feb; 93(2):131-42. PubMed ID: 11738720
[TBL] [Abstract][Full Text] [Related]
2. Finding of an isoleucine derivative of a recombinant protein for pharmaceutical use.
Muramatsu R; Misawa S; Hayashi H
J Pharm Biomed Anal; 2003 Apr; 31(5):979-87. PubMed ID: 12684110
[TBL] [Abstract][Full Text] [Related]
3. [A finding of isoleucine derivative in recombinant protein].
Muramatsu R; Miura A; Misawa S
Tanpakushitsu Kakusan Koso; 2002 Aug; 47(10):1299-304. PubMed ID: 12184069
[No Abstract] [Full Text] [Related]
4. C-terminal proteolytic degradation of recombinant desulfato-hirudin and its mutants in the yeast Saccharomyces cerevisiae.
Heim J; Takabayashi K; Meyhack B; Märki W; Pohlig G
Eur J Biochem; 1994 Dec; 226(2):341-53. PubMed ID: 8001551
[TBL] [Abstract][Full Text] [Related]
5. Identification of unusual replacement of methionine by norleucine in recombinant interleukin-2 produced by E. coli.
Lu HS; Tsai LB; Kenney WC; Lai PH
Biochem Biophys Res Commun; 1988 Oct; 156(2):807-13. PubMed ID: 3056404
[TBL] [Abstract][Full Text] [Related]
6. Novel hirudin variants from the leech Hirudinaria manillensis. Amino acid sequence, cDNA cloning and genomic organization.
Scacheri E; Nitti G; Valsasina B; Orsini G; Visco C; Ferrera M; Sawyer RT; Sarmientos P
Eur J Biochem; 1993 May; 214(1):295-304. PubMed ID: 7685281
[TBL] [Abstract][Full Text] [Related]
7. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
[TBL] [Abstract][Full Text] [Related]
8. Characterization of C-terminal-truncated urinary metabolites of a recombinant hirudin in rats.
Komatsu Y; Hayashi H
Peptides; 1999 Dec; 20(12):1401-9. PubMed ID: 10698114
[TBL] [Abstract][Full Text] [Related]
9. Hirudin and hirudin-based peptides.
Stone SR; Maraganore JM
Methods Enzymol; 1993; 223():312-36. PubMed ID: 8271960
[No Abstract] [Full Text] [Related]
10. beta-methylnorleucine, an antimetabolite produced by Serratia marcescens.
Sugiura M; Kisumi M; Chibata I
J Antibiot (Tokyo); 1981 Oct; 34(10):1278-82. PubMed ID: 7031030
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin activity of the hirudin N-terminal core domain residues 1-43.
Chang JY; Schlaeppi JM; Stone SR
FEBS Lett; 1990 Jan; 260(2):209-12. PubMed ID: 2404798
[TBL] [Abstract][Full Text] [Related]
12. Isolation of recombinant hirudin by preparative high-performance liquid chromatography.
Bischoff R; Clesse D; Whitechurch O; Lepage P; Roitsch C
J Chromatogr; 1989 Aug; 476():245-55. PubMed ID: 2674177
[TBL] [Abstract][Full Text] [Related]
13. Stability of hirudin, a thrombin-specific inhibitor. The structure of alkaline-inactivated hirudin.
Chang JY
J Biol Chem; 1991 Jun; 266(17):10839-43. PubMed ID: 2040604
[TBL] [Abstract][Full Text] [Related]
14. Valyl-tRNA synthetase from Escherichia coli MALDI-MS identification of the binding sites for L-valine or for noncognate amino acids upon qualitative comparative labeling with reactive amino-acid analogs.
Hountondji C; Beauvallet C; Dessen P; Hoang-Naudin C; Schmitter JM; Pernollet JC; Blanquet S
Eur J Biochem; 2000 Aug; 267(15):4789-98. PubMed ID: 10903513
[TBL] [Abstract][Full Text] [Related]
15. Probing the structure of hirudin from Hirudinaria manillensis by limited proteolysis. Isolation, characterization and thrombin-inhibitory properties of N-terminal fragments.
Vindigni A; De Filippis V; Zanotti G; Visco C; Orsini G; Fontana A
Eur J Biochem; 1994 Dec; 226(2):323-33. PubMed ID: 8001550
[TBL] [Abstract][Full Text] [Related]
16. Recombinant expression of selectively sulfated proteins in Escherichia coli.
Liu CC; Schultz PG
Nat Biotechnol; 2006 Nov; 24(11):1436-40. PubMed ID: 17072302
[TBL] [Abstract][Full Text] [Related]
17. Liquid secondary ion mass spectrometry applied to structural confirmation of enzymically prepared C-terminal-truncated derivatives of recombinant hirudin.
Maftouh M; Ponthus C; Tuong A; Picard C
J Chromatogr; 1991 Jan; 562(1-2):421-34. PubMed ID: 2026708
[TBL] [Abstract][Full Text] [Related]
18. Reevaluating the effects of tyrosine iodination of recombinant hirudin on its thrombin inhibition kinetics.
Komatsu Y; Hayashi H
Thromb Res; 1997 Aug; 87(4):343-52. PubMed ID: 9271811
[TBL] [Abstract][Full Text] [Related]
19. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
Myles T; Le Bonniec BF; Betz A; Stone SR
Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
[TBL] [Abstract][Full Text] [Related]
20. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
Dennis S; Wallace A; Hofsteenge J; Stone SR
Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
